Skip to main content

Table 1 Baseline demographics of the intervention group of the MASSIV database

From: Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial

Number of participants selected for analysis from the intervention Arm (%)

Total

3311 (100.0)

Age

 < 5 years

585 (17.7)

 5–15 years

1065 (32.2)

 > 15–25 years

543 (16.4)

  > 25–50

780 (23.6)

  > 50 years

338 (10.2)

Sex

 Female

1780 (53.8)

 Male

1531 (46.2)

Ethnicity

 Fula

2065 (62.4)

 Mandinka

638 (19.3)

 Sarahule

134 (4.1)

 Wollof

3 (0.1)

 Not specified

471 (14.2)

Household Size

  < 6

51 (1.5)

 6–11

391 (11.8)

 12–24

1373 (41.5)

 25–50

1141 (34.5)

  > 50

355 (10.7)

MDA Eligible

 DHP

3291 (99.4)

 Ivermectin

2730 (82.5)